2013
DOI: 10.1371/journal.pone.0083361
|View full text |Cite
|
Sign up to set email alerts
|

Ultra-Deep Pyrosequencing (UDPS) Data Treatment to Study Amplicon HCV Minor Variants

Abstract: We have investigated the reliability and reproducibility of HCV viral quasispecies quantification by ultra-deep pyrosequencing (UDPS) methods. Our study has been divided in two parts. First of all, by UDPS sequencing of clone mixes samples we have established the global noise level of UDPS and fine tuned a data treatment workflow previously optimized for HBV sequence analysis. Secondly, we have studied the reproducibility of the methodology by comparing 5 amplicons from two patient samples on three massive seq… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
49
0
1

Year Published

2014
2014
2020
2020

Publication Types

Select...
8
1
1

Relationship

2
8

Authors

Journals

citations
Cited by 55 publications
(50 citation statements)
references
References 31 publications
0
49
0
1
Order By: Relevance
“…The raw data were treated as described previously with minor refinements (36). Reads obtained from UDPS were demultiplexed corresponding to each sample combination of a multiplex identifier and primer to generate a FASTA file with each sample.…”
Section: Methodsmentioning
confidence: 99%
“…The raw data were treated as described previously with minor refinements (36). Reads obtained from UDPS were demultiplexed corresponding to each sample combination of a multiplex identifier and primer to generate a FASTA file with each sample.…”
Section: Methodsmentioning
confidence: 99%
“…Clonal sequencing is more sensitive, but also more expensive and time-consuming. These limitations are overcome by a technique known as deep sequencing, which allows detection of minor variants present at frequencies as low as 0.5% [70].At present, none of these techniques are commercially available, but a number of laboratories are able to perform sequence analysis of the NS3-4A, NS5A, and NS5Bregions. Nonetheless, the use of these methods in clinical practice is limited, and currently, their interpretation requires expert guidance.…”
mentioning
confidence: 99%
“…As such, we cannot ignore the possibility that in vitro recombination artifacts may also be present in the final data set. The acceptance of low-frequency recombinants requires critical evaluation weighed against the documented preva-lence and characteristics of in vitro artifacts (28,(48)(49)(50). To that end, we submit four main arguments in support of our broader recombination findings.…”
Section: Discussionmentioning
confidence: 85%